189 related articles for article (PubMed ID: 1975199)
1. Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist--a randomized, double-blind cross-over study in healthy male volunteers.
Karhuvaara S; Kallio A; Scheinin M; Anttila M; Salonen JS; Scheinin H
Br J Clin Pharmacol; 1990 Jul; 30(1):97-106. PubMed ID: 1975199
[TBL] [Abstract][Full Text] [Related]
2. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers.
Scheinin H; Aantaa R; Anttila M; Hakola P; Helminen A; Karhuvaara S
Anesthesiology; 1998 Sep; 89(3):574-84. PubMed ID: 9743392
[TBL] [Abstract][Full Text] [Related]
3. Rapid reversal of alpha 2-adrenoceptor agonist effects by atipamezole in human volunteers.
Karhuvaara S; Kallio A; Salonen M; Tuominen J; Scheinin M
Br J Clin Pharmacol; 1991 Feb; 31(2):160-5. PubMed ID: 1675577
[TBL] [Abstract][Full Text] [Related]
4. Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans.
Huupponen R; Karhuvaara S; Anttila M; Vuorilehto L; Scheinin H
Clin Pharmacol Ther; 1995 Nov; 58(5):506-11. PubMed ID: 7586944
[TBL] [Abstract][Full Text] [Related]
5. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.
Haapalinna A; Leino T; Heinonen E
Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451
[TBL] [Abstract][Full Text] [Related]
6. Assessment of MK-912, an alpha 2-adrenoceptor antagonist, with use of intravenous clonidine.
Warren JB; Dollery CT; Fuller RW; Williams VC; Gertz BJ
Clin Pharmacol Ther; 1989 Jul; 46(1):103-9. PubMed ID: 2568210
[TBL] [Abstract][Full Text] [Related]
7. Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2-adrenoceptor agonist, in healthy volunteers.
Scheinin M; Kallio A; Koulu M; Viikari J; Scheinin H
Br J Clin Pharmacol; 1987 Oct; 24(4):443-51. PubMed ID: 2891369
[TBL] [Abstract][Full Text] [Related]
8. Effect of medetomidine and its antagonism with atipamezole on stress-related hormones, metabolites, physiologic responses, sedation, and mechanical threshold in goats.
Carroll GL; Hartsfield SM; Champney TH; Geller SC; Martinez EA; Haley EL
Vet Anaesth Analg; 2005 May; 32(3):147-57. PubMed ID: 15877661
[TBL] [Abstract][Full Text] [Related]
9. A pharmacokinetic study including some relevant clinical effect of medetomidine and atipamezole in lactating dairy cows.
Ranheim B; Arnemo JM; Ryeng KA; Søli NE; Horsberg TE
J Vet Pharmacol Ther; 1999 Dec; 22(6):368-73. PubMed ID: 10651465
[TBL] [Abstract][Full Text] [Related]
10. Effects of atipamezole--a selective alpha-adrenoceptor antagonist--on cardiac parasympathetic regulation in human subjects.
Penttilä J; Kaila T; Helminen A; Anttila M; Karhuvaara S; Huhtala S; Scheinin H
Auton Autacoid Pharmacol; 2004 Jul; 24(3):69-75. PubMed ID: 15541014
[TBL] [Abstract][Full Text] [Related]
11. Alpha 2-adrenoceptor-mediated inhibition of gastric acid secretion by medetomidine is efficiently antagonized by atipamezole in rats.
Savola M; Savola JM; Puurunen J
Arch Int Pharmacodyn Ther; 1989; 301():267-76. PubMed ID: 2576195
[TBL] [Abstract][Full Text] [Related]
12. Reversal of medetomidine-induced sedation in reindeer (Rangifer tarandus tarandus) with atipamezole increases the medetomidine concentration in plasma.
Ranheim B; Horsberg TE; Nymoen U; Søli NE; Tyler NJ; Arnemo JM
J Vet Pharmacol Ther; 1997 Oct; 20(5):350-4. PubMed ID: 9350254
[TBL] [Abstract][Full Text] [Related]
13. The clinical effectiveness of atipamezole as a medetomidine antagonist in the dog.
Vähä-Vahe AT
J Vet Pharmacol Ther; 1990 Jun; 13(2):198-205. PubMed ID: 1974650
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist.
Pertovaara A; Haapalinna A; Sirviö J; Virtanen R
CNS Drug Rev; 2005; 11(3):273-88. PubMed ID: 16389294
[TBL] [Abstract][Full Text] [Related]
15. The role of alpha-2-adrenoceptors in the control of ACTH secretion; interaction with the opioid system.
al-Damluji S; Bouloux P; White A; Besser M
Neuroendocrinology; 1990 Jan; 51(1):76-81. PubMed ID: 1968233
[TBL] [Abstract][Full Text] [Related]
16. The antagonistic effects of atipamezole and yohimbine on stress-related neurohormonal and metabolic responses induced by medetomidine in dogs.
Ambrisko TD; Hikasa Y
Can J Vet Res; 2003 Jan; 67(1):64-7. PubMed ID: 12528832
[TBL] [Abstract][Full Text] [Related]
17. Effects of yohimbine, an alpha 2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension.
Verwaerde P; Tran MA; Montastruc JL; Senard JM; Portolan G
Fundam Clin Pharmacol; 1997; 11(6):567-75. PubMed ID: 9444525
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of medetomidine and atipamezole in dairy calves: an agonist-antagonist interaction.
Ranheim B; Søli NE; Ryeng KA; Arnemo JM; Horsberg TE
J Vet Pharmacol Ther; 1998 Dec; 21(6):428-32. PubMed ID: 9885964
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of a benzofuroquinolizine alpha 2-adrenoceptor antagonist.
Gertz BJ; Vlasses PH; Rocci ML; Coker LD; Williams V; Bjornsson TD; Jones KH
Clin Pharmacol Ther; 1989 Nov; 46(5):566-75. PubMed ID: 2573444
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic effects of atipamezole and yohimbine on xylazine-induced diuresis in healthy dogs.
Talukder H; Hikasa Y; Matsuu A; Kawamura H
J Vet Med Sci; 2009 May; 71(5):539-48. PubMed ID: 19498277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
